Although several studies linked PON2 variants to various diseases like amyotrophic lateral sclerosis [33,34], Alzheimer's disease [35], CHD [14-16], and metabolic traits [18] with controversial findings [36], there is no published study that links PON2 with SLE risk. This evidence concerns the gene PON2 and early-onset autosomal dominant Alzheimer disease.